Pharmaceutical Metrics: Measuring and Improving R & D Performance
Autor David S. Zuckermanen Limba Engleză Paperback – 6 mar 2017
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 335.19 lei 6-8 săpt. | |
Taylor & Francis – 6 mar 2017 | 335.19 lei 6-8 săpt. | |
Hardback (1) | 757.04 lei 6-8 săpt. | |
Taylor & Francis – 18 ian 2006 | 757.04 lei 6-8 săpt. |
Preț: 335.19 lei
Preț vechi: 386.77 lei
-13% Nou
Puncte Express: 503
Preț estimativ în valută:
64.15€ • 68.10$ • 53.45£
64.15€ • 68.10$ • 53.45£
Carte tipărită la comandă
Livrare economică 26 decembrie 24 - 09 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781138254763
ISBN-10: 1138254762
Pagini: 148
Dimensiuni: 210 x 297 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
ISBN-10: 1138254762
Pagini: 148
Dimensiuni: 210 x 297 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom
Public țintă
Professional Practice & DevelopmentCuprins
Contents: The case for Metrics; Selecting a Metrics System; Creating the Foundation Using Strategy Maps; Developing Performance Metrics; Rounding out Your R & D Scorecard: Developing Financial, Customer and Organizational Growth Metrics; Metric Tips and Tricks; Displaying your Metrics; Closing the Strategy Loop. Index.
Notă biografică
David S. Zuckerman is the world's foremost expert in the area of pharmaceutical R &D metrics, and lectures internationally on pharmaceutical metrics and balanced scorecards. He is owner and principal of Customized Improvement Strategies LLC - a management consulting firm that focuses on process improvement, organizational development, leadership development and change management; with clients that include large and small pharma R& D organizations, CROs and academic medical centers. Find out more about his work at www.rx-business.com
Recenzii
'This book's discussion of metrics and use of examples for the pharmaceutical industry is outstanding. The focus of this book may be the pharmaceutical industry, but the approach should be used in any business situation that measures and evaluates processes. I finally have a standard metrics reference for my team to utilize.' Timothy D. Hoos, Director, R&D Finance, Outsourcing, and Contracts 'This a book that should reside on the desk of everyone involved in Pharmaceutical R&D, a book that should not only be read but used as a reference guide by all senior staff.' Bill Taaffe, President Corporate Development, ICON Clinical Research A welcomed and needed addition to the field of drug development. David Zuckerman, a noted expert in this area brings a rigorous, quantitative, and disciplined approach to the planning and management of projects in the pharmaceutical industry. This is an important guide and resource for anyone working on bringing a drug product forward through R&D, registration, and commercialization.' Jeffrey W. Sherman, MD, FACP, Chief Medical Officer and Executive Vice President, NeoPharm, Inc. 'I read this book with great pleasure. It is concise and fun to read, particularly that the topic is a relatively abstractive one. People who read this book will realise that while it may not be difficult to compile a metrics report, it is a challenging job to do it right. As the environment requires us to develop new medicines efficiently and cost effectively, you will find this book a valuable resource for improving trial and drug development performance.' Gen Li, Ph.D., MBA, Head of Development Operations Productivity, PGRD Pfizer Inc. 'This practical and authoritative book will be essential reading for everyone directly involved with driving performance improvements within their organization, and a useful guide for others working in organizations that are not currently implementing (or are mis-implementing) performance improvement schemes.' Clinical Research Focus, May 2006
Descriere
David Zuckerman's highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R & D, supported by case studies of the techniques applied and tips for optimizing the system.